European Brachytherapy Market
- Report Code: BR 1000
- Publish Date: Upcoming
The European brachytherapy market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing age related chronic diseases. The market was valued $50 million in 2013 and is expected to be $54 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body.
The report “European Brachytherapy Market Forecast, 2010-2018", analyzes the market of devices into three types of brachytherapy such as high dose rate, pulsed dose rate, and permanent seed. The technique has been successfully used against cervix, prostate, breast and skin cancer.
Factors such as high patient pool, growing preferences to minimally invasive surgery, geographical expansion of market players, increased government investment in healthcare facilities especially in rural areas, westernization in life style and dietary habits, increasing healthcare expenditure & improving medical insurance plans, are driving the European brachytherapy market.
European market is challenging, as it is a heterogeneous region in terms of regulatory and reimbursement approaches, with every country having its own unique characteristics. Recent trends show an increased inclination of companies towards Europe for their preliminary products development and launch. In addition, it is observed that capital investment required for regulatory approval of the product is significantly less than that compared to U.S. Ultimately market players are adopting a strategy to launch their products initially in Europe, as it offers an opportunity to balance the risk-to-reward ratio in case of innovative technologies.
The report also provides an extensive competitive landscaping of companies operating in European brachytherapy market. The key players of the market covered in this report are Varian Medical Systems (U.S), and ELEKTA (Sweden).
The segment and country-specific company shares, News & Deals, M&A, segment-specific pipeline products, product approvals and product recalls of the major companies is also covered in the report.
Customization Options
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get an insight to industry standards and deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence and patient pool of cancer, cardiovascular disorders, gynecological, and orthopedic disorders
- Disease progression (pattern analysis)
Surgeon's/Physician's Perception Analysis
- Fast turn-around analysis of surgeon's response to market events and trends
- Surgeon's opinion about products from different companies
- Surgeon's qualitative inputs on epidemiology date
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Alternative Products: Impact analysis
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
